首页>Drug delivery and translational research>Development of antibody-modified chitosan nanoparticles for the targeted delivery of si A across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes
Development of antibody-modified chitosan nanoparticles for the targeted delivery of si A across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes